Daniil Gataulin Stock Analyst Profile - Chardan Capital Research Coverage - Stocknear

Daniil Gataulin

Stock Analyst at Chardan Capital

(5)
# 133
Out of 5,493 analysts
122
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

21 Stocks

Name Action PT Current % Upside Ratings Updated
QURE uniQure
Maintains: Strong Buy
35 76
54.31 39.94% 8 Sep 25, 2025
OCGN Ocugen
Maintains: Buy
7 7
1.46 379.45% 14 Sep 19, 2025
OCUL Ocular Therapeutix
Initiates Coverage On: Buy
21
12.53 67.6% 1 Sep 15, 2025
TRML Tourmaline Bio
Downgrades: Neutral
70 48
47.74 0.54% 4 Sep 10, 2025
RGNX Regenxbio
Maintains: Buy
52 52
9.65 438.86% 13 Sep 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 3
0.97 209.28% 10 Aug 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
61 61
13.84 340.75% 6 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 10
2.41 314.94% 1 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 35
8.18 327.87% 5 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
33 33
4.51 631.71% 8 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
8.28 81.16% 7 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 4
1.33 200.75% 8 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 27
13.9 94.24% 12 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 33
17.63 87.18% 7 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 4
n/a n/a 4 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
220 220
0.6 36566.67% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 13
n/a n/a 2 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
n/a n/a 2 Sep 28, 2022